Dashboard PDUFA PDUFA History Dilution Watch Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track NNVC with free AI briefings, catalyst countdowns, and dilution alerts.

NNVC · NanoViricides, Inc.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$2.8M Cash on Hand
4.1mo Cash Runway
2.4% Short Interest
$6 Analyst Target (2)
Follow NNVC by email Get an email when NNVC pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about NNVC, unsubscribe in one click. Privacy

💰 Cash Runway & Dilution Risk

NNVC holds $2.8M in cash and short-term investments (as of Jun 30, 2026) and burns about $2M/quarter from operations, an estimated runway of 4.1 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 84 · High

Recent financing filings on SEC EDGAR:

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when NNVC files for a raise →

👥 Who Owns NNVC

Insiders 1.9% Institutions (50 holders) 9.3% Public and other holders 88.8%
HolderTypeShares% of sharesAs of
Vanguard Capital Management LLC Institution (13F) 919,313 3.60% 2026-06-30
Milton Boniuk
10% Owner before reverse split · +16,850 options
Insider 491,721 1.93% 2017-02-21
Geode Capital Management, LLC Institution (13F) 216,022 0.85% 2026-06-30
Connective Capital Management LLC Institution (13F) 185,217 0.73% 2026-06-30
Blackrock Inc. Institution (13F) 158,753 0.62% 2026-06-30
Vanguard Fiduciary Trust Co Institution (13F) 131,923 0.52% 2026-06-30
Renaissance Technologies, LLC Institution (13F) 128,600 0.50% 2026-06-30
Miller Financial Services LLC Institution (13F) 112,000 0.44% 2026-06-30
UBS Group AG Institution (13F) 99,331 0.39% 2026-06-30
Creative Planning Institution (13F) 86,761 0.34% 2026-06-30
Susquehanna International Group, LLP Institution (13F) 60,616 0.24% 2026-06-30

Share count 25,525,000 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest (13F quarter ending 2026-06-30). Sources have different dates, so the split is approximate. Source: SEC EDGAR.

Get the full NNVC picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for NNVC and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.